PCN PIMCO CORPORATE & INCOME STRATEGY FUND

BEARISH Impact: 4/10 424B5
Horizon weeks Filed Jun 4, 2026 Processed 2d 1h ago SEC 0001193125-26-257769
Notable filing: 424B5

Price Chart

Loading chart...

Executive Summary

PIMCO Corporate & Income Strategy Fund (PCN) filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $350 million in common shares through JonesTrading. The fund previously raised ~$421.6 million from similar ATM sales of 31.526M shares. Shares trade at a ~3.98% premium to NAV. The proceeds will be invested per the fund's income-focused strategy, but the potential for continuous equity issuance at a premium to NAV creates dilution risk and may pressure the stock's premium.

Actionable Insight

The ATM program gives the fund flexibility to issue up to $350M in common shares at prevailing market prices, but only when trading at a premium to NAV. Monitor daily trading volume and premium/discount — sustained ATM selling at a premium can cap the stock's upside and gradually erode the premium. The fund's accumulated loss deepened pro forma, suggesting higher distributions may be funded by capital gains or return of capital. If the premium narrows below 1-2%, ATM issuance likely pauses. For traders, the risk is a creeping overhang rather than an immediate shock; watch for volume spikes.

Key Facts

  • Offering size: up to $350,000,000 in common shares via ATM program with JonesTrading.
  • JonesTrading receives up to 1.00% commission on gross proceeds.
  • As of April 30, 2026, prior ATM sales total 31,526,520 shares for net proceeds of $421,632,646.
  • Last sale price $12.02 vs. NAV $11.56 per share on April 30, 2026 (3.98% premium).
  • Assumed net proceeds of ~$346 million at $12.02/sh, after 1% commission and $468,988 estimated expenses.
  • Proceeds to be invested per fund's income and capital preservation objectives within ~30 days.
  • Cumulative distributable earnings (accumulated loss) were $(141.7M) actual and $(171.1M) pro forma as of Dec 31, 2025.
  • No guarantee of any sales under the program; sales cannot occur below NAV per 1940 Act.

Financial Impact

Up to $350 million in new common shares (29.1M shares at assumed $12.02), representing ~39% dilution vs. 74.7M shares outstanding. Net proceeds estimated at ~$346M after 1% commission and expenses. Prior ATM raised $421.6M from 31.5M shares.

dilutionsharesOutstandingnetAssetValue

Risk Factors

  • Dilution risk from up to 29.1M new shares (~39% of current outstanding), which could pressure the stock's premium.
  • Potential for continuous overhang if the fund actively uses the ATM, limiting price appreciation.
  • Cumulative distributable losses of $(141.7M) actual and $(171.1M) pro forma may result in return-of-capital distributions.
  • The fund's high-yield and leveraged portfolio is sensitive to credit spreads and interest rates.

Market Snapshot

Exchange
NYSE

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001193125-26-257769
Document: 0001193125-26-257769-index-headers.html0001193125-26-257769
Document: 0001193125-26-257769-index.html0001193125-26-257769
Document: 0001193125-26-257769.txt0001193125-26-257769

US Market Status

Market Closed — Opens Mon (14h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access